BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10550830)

  • 1. Concurrent chemotherapy and radiotherapy in patients with brain tumors.
    Glantz MJ; Kim L; Choy H; Akerley W
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):78-82. PubMed ID: 10550830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motexafin gadolinium: a clinical review of a novel radioenhancer for brain tumors.
    Khuntia D; Mehta M
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):981-9. PubMed ID: 15606327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motexafin gadolinium: a novel radiosensitizer for brain tumors.
    Francis D; Richards GM; Forouzannia A; Mehta MP; Khuntia D
    Expert Opin Pharmacother; 2009 Sep; 10(13):2171-80. PubMed ID: 19640206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concomitant chemoradiotherapy and malignant glial tumors in the adult].
    Honnorat J
    Cancer Radiother; 1998 Dec; 2(6):672-8. PubMed ID: 9922772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motexafin gadolinium: a novel radiosensitizer for brain tumors.
    Forouzannia A; Richards GM; Khuntia D; Mehta MP
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):785-94. PubMed ID: 17555388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemoradiation for malignant brain tumors].
    Matsutani M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2042-8. PubMed ID: 9388512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.
    Fogh S; Machtay M; Werner-Wasik M; Curran WJ; Bonanni R; Axelrod R; Andrews D; Dicker AP
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1009-16. PubMed ID: 19879067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS; McCarley DL; Zlotecki RA
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiation and combined treatment of anaplastic neuroepithelial neoplasms].
    Ragaĭshene VN; Iuozaĭtite EV
    Med Radiol (Mosk); 1989 Dec; 34(12):30-6. PubMed ID: 2601590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly, outpatient paclitaxel and concurrent cranial irradiation in adults with brain tumors: preliminary results and promising directions.
    Glantz MJ; Choy H; Kearns CM; Akerley W; Egorin MJ
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):26-32. PubMed ID: 7481858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicities in RTOG combined-modality trials for inoperable non-small-cell lung cancer.
    Byhardt RW
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):116-20. PubMed ID: 10550835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).
    van Vulpen M; Kal HB; Taphoorn MJ; El-Sharouni SY
    Oncol Rep; 2002; 9(4):683-8. PubMed ID: 12066192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response.
    Glantz MJ; Choy H; Akerley W; Kearns CM; Egorin MJ; Rhodes CH; Cole BF
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):128-35. PubMed ID: 9007140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-brain radiotherapy in the management of brain metastasis.
    Khuntia D; Brown P; Li J; Mehta MP
    J Clin Oncol; 2006 Mar; 24(8):1295-304. PubMed ID: 16525185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in chemotherapy for brain tumors.
    Conrad CA; Milosavljevic VP; Yung WK
    Neurol Clin; 1995 Nov; 13(4):795-812. PubMed ID: 8583997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does chemotherapy benefit the patient with a central nervous system glioma?
    Rodriguez LA; Levin VA
    Oncology (Williston Park); 1987 Nov; 1(9):29-36, 40-1. PubMed ID: 3079493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.